Microbicide Trials Network

MTN-020 - ASPIRE


ASPIRE - A Study to Prevent Infection with a Ring for Extended Use – is a Phase III safety and effectiveness trial of a vaginal ring containing the antiretroviral dapivirine that opened in August 2012 and enrolled 2,629 women at several sites in Africa. The dapivirine vaginal ring was developed by the International Partnership for Microbicides, which is conducting another Phase III trial, The Ring Study, in parallel with ASPIRE.

 

See

ASPIRE Phase III trial of a vaginal ring for HIV prevention completes enrollment of 2,629 women

26-June-2014

  

Phase III Trial of Dapivirine Ring Begins in Africa: ASPIRE testing new HIV prevention approach for women

24-July-2012

  

ASPIRE Backgrounder

7-October-2013  

  

Two Phase III Sister Studies of a Microbicide Ring to Prevent HIV:

The Ring Study and ASPIRE

7-Octoboer-2013

  

ASPIRE Q&A

7-October-2013

 

See Also

MTN-020 – ASPIRE Protocol